Bruker, Stratagene Shares Give Back Gains | GenomeWeb

Shares in Bruker BioSciences and Stratagene both declined more than 5 percent for the tracking period ended Tuesday, leading the way among the 10 companies in the BCW Index whose shares declined during the period. Stratagene's shares dropped 7.22 percent, far exceeding the 5.59-percent gain registered the week before, while shares in Bruker dropped 5.32 percent, giving back part of its 9.89-percent gain last week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.